Abolis is an impact-driven
biotech innovator
Abolis develops high-impact innovations that support industries in their transition to build a better future in collaboration with nature. We provide tailor-made industrial solutions based on micro-organisms for a wide range of industries – from food and health to cosmetics and chemistry.
We help industries transition to a more sustainable model
Industries face an existential crisis that challenges the paradigms our world is built one, such as energy sources, raw materials, manufacturing models and product lifecycles. Bringing Biology into industries paves the way for a more sustainable future. And we can make it happen now.
Industries face an existential crisis that challenges the paradigms our world is built one, such as energy sources, raw materials, manufacturing models and product lifecycles. Bringing Biology into industries paves the way for a more sustainable future. And we can make it happen now.
We help industries transition to a more sustainable model
Industries face an existential crisis that challenges the paradigms our world is built one, such as energy sources, raw materials, manufacturing models, supply chains and product lifecycles. Bringing Biology into industries paves the way for a more sustainable future. And we can make it happen now.
Biodegradable
products by design
Abolis is an impact-driven
biotech innovator
Abolis delivers high-impact innovations that support industries in their transition to build a better future in collaboration with nature. We provide tailor-made industrial solutions based on micro-organisms for a wide range of industries – from food and healthcare to cosmetics and chemistry.
Biodegradable
products by design
Supply-chain resiliency
Greenhouse gas
reduction
Environmental safety
Sustainable raw materials sources Healthcare
Innovation
We deliver tailor-made industrial solutions based on micro-organisms to rethink production models
We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions. These offer economically and environmentally sustainable alternatives to petrochemical-based products and ingredients, or plant extracts.
Biomanufacturing is the process of utilizing living organisms, such as bacteria, yeast, or mammalian cells, to produce valuable products at scale. This innovative approach combines biology and manufacturing to create a wide range of goods, including pharmaceuticals, biofuels, enzymes and chemicals. By harnessing the biological processes of these natural or modified microorganisms, biomanufacturing offers a sustainable and often more efficient alternative to traditional manufacturing methods. This method has gained prominence for its ability to yield high-quality products with a reduced environmental impact, contributing to the growing field of sustainable industrial practices.
Biotechnologies have the potential to generate significant value for your company, contributing to innovation and efficiency across various dimensions:
✓ Product Innovation: Biotechnologies facilitate the development of novel and improved products.
✓ Cost Efficiency: Particularly for complex or hard-to-find products, biotechnologies often outperform traditional production methods.
✓ Sustainability: Biotechnologies play a crucial role in reducing the environmental impact of industrial processes and product end of life. They are not relying on fossil raw materials.
✓ Customization: In the healthcare sector, biotechnologies are paving the way for personalized medicine and innovative treatments. These advancements address various challenges, including microbiome dysbiosis, optimizing production costs and reducing the carbon footprint associated with manufacturing processes.
✓ Competitive Advantage: By staying at the forefront of sustainable innovation, companies can gain a competitive edge.
✓ Product Portfolio Diversification: Our technology provides opportunities for the development of a diverse range of products. You can explore new markets and revenue streams by applying biotechnological solutions.
Embracing biotechnologies not only allows companies to improve existing processes but also opens new avenues for growth, innovation, and sustainability in an increasingly challenging business landscape.
Yes, a bioprocess can be competitive in different ways: cost efficiency, sustainability. It can outperform its conventional competitors, product lifecycle, or meeting market demand for new products.
For products that are hard to find, manufacture or extract, it offers a more efficient production method. Additionally, it enables the production of biodegradable products not accessible through which conventional chemistry.
Regulatory compliance is a crucial part of the equation. With a bioprocess, you can meet or surpass environmental and safety requirements.
All those elements should be studied in detail before starting the development of a new biobased product. The first stage of your collaboration with Abolis will be to study the business case in depth, before starting any development.
If a microorganism produces a molecule already existing in nature (in plants, animals, etc.), the product is considered natural by the main authorities (US, EU). According to current regulations, if the product contains less than 10 ng/g of recombinant DNA after purification, then it is considered GMO-free.
Our expertise extends beyond replacing your current process for a given molecule with a bioprocess for the exact same molecule.
We can assist you in developing products that are biobased, biodegradable and safe by design.
Let us surprise you. The solutions may significantly differ from your initial thoughts!
We do! We have created a business unit dedicated to Microbiome, it’s called “Microbiome Studio” and the entity is based in Paris, Station F, the “world’s biggest startup campus”. Microbiome Studio is a software solution able to decipher the microbiome and to build themetabolic maps of the ecosystem.
Going far beyond simply counting microbial species, it explores the metabolic pathways and the interaction of the species. The applications are numerous, including everything fromhealthcare, food and agriculture to cosmetics and beyond.
To learn more, check out www.microbiomestudio.com
If you don’t have in-house fermentation capacities, there are several options. If your production does not need large volume, we can help you finding the right contract manufacturer.
If your production volume is significant, you may benefit from building a workshop or facilityin your existing plant or at a location close to the feedstock. You may also consider partnership with dedicated installations in an existing factory.
We are “Industry Oriented”: we consider industrial constraints, including IP, at the project’s outset.
Choosing the right strain for the objective is crucial, utilizing our collection of strains or external banks. We build the proper industrial Scale-down. To ensure Free to Operate (FTO) and commercial use, we use rational design to build the strain producing your molecule or protein.
Our expertise spans Computer Science, Biology, Genetics, Robotics, Analysis, Fermentation and IP.
Abolis has developed innovative genetic and modeling tools, along with a variety of “omics” tools. Additionally, our engaged team ensures best practices project management, through regular meetings and steering committees to make informed decisions for the project.
FAQ
All transformation is raising questions.
We’ve got answers.
We are Abolis
We deliver tailor-made industrial solutions based on micro-organisms to rethink production models
We rely on biotechnologies and the untapped potential of micro-organisms to develop new bioproduction solutions. These offer economically and environmentally sustainable alternatives to petrochemical-based products and ingredients, or plant extracts.
Industries
Sustainable new ways to feed the planet
“Our companies have been working together since 2021 and we are still amazed by Abolis’steam. Engaged, resourceful and technically excellent. Our values are totally aligned and at Htba we are delighted with this partnership and truly believe that together we can create more value for our customers.”
Alexandre Valls-Coma, CEO, Htba
“Upon creation of bYoRNA, it was evident to us that Abolis would be a key partner to achieve our objectives. Thanks to the strong expertise of the Abolis team, we achieved significant positive results in a very short time.”
Thierry Zielger, co-founder, bYoRNA
Biodegradable
products by design
Supply-chain resiliency
Greenhouse gasreduction
Environmental safety
Sustainable raw materials sources Healthcare
Innovation